RNAC Stock Analysis: Buy, Sell, or Hold?

RNAC - Cartesian Therapeutics, Inc. Common Stock

PHARMACEUTICAL PREPARATIONS
$10.18
0.23 (2.31%) ▲
5d: +18.37%
30d: +52.4%
90d: +54.24%
HOLD
MODERATE Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Aug 06, 2026

Get Alerted When RNAC Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
📊 HOLD - EXTENDED: RNAC is 14.9% above its trading range ($8.86). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
See Forward Earnings Fair Value & Price Prediction →

In-depth Analysis How we analyze

Valuation Analysis: RNAC is currently trading at $10.18, which is considered extended relative to its 30-day fair value range of $6.17 to $8.86.

Technical Outlook: Technically, RNAC is showing sideways momentum. The price is approaching resistance at $9.33. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.

Market Sentiment: RNAC has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $34.57 (+239.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position EXTENDED
Historical Trading Range $6.17 - $8.86
Company Quality Score 56/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 52.6%

All Signals

  • BEARISH: Price significantly overextended (+14.9% above its trading range)
  • BULLISH: Strong technical setup (75/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 239.6% below Wall St target ($34.57)

Trading Range Analysis

30-Day Trading Range $6.17 - $8.86
Current vs Trading Range EXTENDED

Support & Resistance Levels

Support Level $5.77
Resistance Level $9.33
Current Trend Sideways
Technical data as of Jun 9, 2026

Fundamental Context

Forward P/E (Next Year Est.) -3.80
Wall Street Target $34.57 (+239.6%)
Revenue Growth (YoY) -92.9%
Earnings Growth (YoY) -7.4%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: June 23, 2026 11:35 PM ET
Data refreshes hourly during market hours. Next update: 12:35 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Blaine Davis SELL 10591 shares 2026-01-06
Milos Miljkovic SELL 3573 shares 2026-01-06

Unlock Insider Activity

See real-time buying/selling by company executives for RNAC.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
RARE
Ultragenyx
STRONG BUY
20 analysts
$52 64 BUY
AXSM
Axsome Therapeutics Inc
STRONG BUY
19 analysts
$276 59 HOLD
VKTX
Viking Therapeutics Inc
STRONG BUY
19 analysts
$93 65 BUY
CRNX
Crinetics Pharmaceutical…
STRONG BUY
17 analysts
$83 61 BUY
INCY
Incyte Corporation
HOLD
27 analysts
$109 60 BUY

More Analysis for RNAC

RNAC Technical Chart RNAC Price Prediction RNAC Earnings Date RNAC Investment Advisor RNAC Fair Price Analyzer RNAC Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals